Ibandronic acid Na salt | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ibandronic Acid Na Salt
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Ibandronic acid Na salt

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 14 USDMF, 3 CEP/COS, 1 JDMF, 6 EU WC, 25 KDMF, 6 NDC API, 20 Listed Suppliers, $ API Reference Price

54 API Suppliers
14 USDMF
3 CEP/COS
1 JDMF
6 EU WC
25 KDMF
6 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

202 FDF Dossiers, 21 FDA Orange Book, 134 Europe, 1 Australia, 10 South Africa, 36 Listed Dossiers

202 FDF Dossiers
21 FDA Orange Book
134 Europe
1 Australia
10 South Africa
36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - EQ 3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - EQ 3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 4 SPI Pharma, 6 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 22 BASF, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 1 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 47 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 22 Granulation, 22 Lubricants & Glidants, 21 Thickeners and Stabilizers, 19 Direct Compression, 19 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 15 Topical, 13 Solubilizers, 12 Parenteral, 9 Co-Processed Excipients, 8 Taste Masking, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

49 Coating Systems & Additives
47 Fillers, Diluents & Binders
25 Controlled & Modified Release
22 Granulation
22 Lubricants & Glidants
21 Thickeners and Stabilizers
19 Direct Compression
19 Film Formers & Plasticizers
17 Disintegrants & Superdisintegrants
15 Topical
13 Solubilizers
12 Parenteral
9 Co-Processed Excipients
8 Taste Masking
7 Chewable & Orodispersible Aids
6 Emulsifying Agents
6 Rheology Modifiers
5 API Stability Enhancers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
1 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 112 Regulatory FDF Prices

9 US Medicaid Prescriptions
112 Regulatory FDF Prices

MARKET PLACE

6 APIs, 3 FDF Dossiers

6 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

$ API Ref.Price (USD/KG) : 920 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Gowling Lafleur Henderson LLP

filter Patent Reset all filters

1 All

01 12346662

filter Product Reset all filters

1 All

01 1Ibandronate

filter Dosage Reset all filters

1 All

01 1Tablet

filter Exp Date Reset all filters

1 All

01 12019-10-01

Product Main Page

01

Gowling Lafleur Henderson LLP

Ibandronate Sodium

CPHI Shenzhen

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-10-01

Date Granted : 2006-05-09

Ibandronate Sodium

Brand Name : BONVIVA

Patent Number : 2346662

Filing Date : 1999-10-01

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-10-01

Date Granted : 2006-05-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!